Report period | 2020 | 2021 | 2022 | 2023 | 2024 | Q1 25 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
HLI:US | Houlihan Lokey | Common share | - | US4415931009 | $125.5 |
Company name | Houlihan Lokey |
---|---|
Sector | Financials / Diversified Financials / Capital Markets / Diversified Capital Markets |
Business address | 10250 Constellation Boulevard 5th Floor Los Angeles, CA 90067 United States |
Mailing address | 10250 Constellation Boulevard 5th Floor Los Angeles, CA 90067 United States |
Website | investors.hl.com |